We are live on ! Find out more
BC

Bridgefront Capital Portfolio holdings

AUM $402M
1-Year Est. Return 18.17%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+18.17%
3 Year Est. Return
+38.15%
5 Year Est. Return
+29.06%
10 Year Est. Return
AUM
$398M
AUM Growth
+$57.9M
Cap. Flow
+$62.7M
Cap. Flow %
15.76%
Top 10 Hldgs %
9.72%
Holding
829
New
268
Increased
140
Reduced
84
Closed
337

Top Buys

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$5.85M
2
MSFT icon
Microsoft
MSFT
+$3.81M
3
MCD icon
McDonald's
MCD
+$3.5M
4
VEEV icon
Veeva Systems
VEEV
+$3.39M
5
GIS icon
General Mills
GIS
+$3.2M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$4.81M
2
HON icon
Honeywell
HON
+$3.09M
3
GWRE icon
Guidewire Software
GWRE
+$2.64M
4
V icon
Visa
V
+$2.58M
5
MO icon
Altria Group
MO
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Consumer Discretionary 13.84%
3 Healthcare 13.56%
4 Industrials 13%
5 Financials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCAT icon
426
Red Cat Holdings
RCAT
$1.16B
$239K 0.06%
+30,103
New +$288K
GSAT icon
427
Globalstar
GSAT
$10.2B
$238K 0.06%
+3,894
New +$215K
DYN icon
428
Dyne Therapeutics
DYN
$4.04B
$235K 0.06%
12,018
-6,024
-33% -$114K
OPRA
429
Opera Ltd
OPRA
$1.65B
$235K 0.06%
16,580
+2,914
+21% +$43K
HRI icon
430
Herc Holdings
HRI
$5.43B
$232K 0.06%
+1,563
New +$214K
PRCT icon
431
Procept Biorobotics
PRCT
$950M
$230K 0.06%
7,326
+843
+13% +$28K
MDGL icon
432
Madrigal Pharmaceuticals
MDGL
$12.6B
$229K 0.06%
393
-323
-45% -$165K
APLD icon
433
Applied Digital
APLD
$7.77B
$227K 0.06%
+9,264
New +$267K
SMTC icon
434
Semtech
SMTC
$11.7B
$226K 0.06%
+3,064
New +$217K
TR icon
435
Tootsie Roll Industries
TR
$2.82B
$225K 0.06%
+6,315
New +$239K
COIN icon
436
Coinbase
COIN
$41.7B
$225K 0.06%
+993
New +$296K
HTHT icon
437
Huazhu Hotels Group
HTHT
$12.4B
$224K 0.06%
+4,765
New +$206K
EXPD icon
438
Expeditors International
EXPD
$22.9B
$221K 0.06%
+1,481
New +$202K
OLN icon
439
Olin
OLN
$2.64B
$220K 0.06%
+10,565
New +$228K
VIPS icon
440
Vipshop
VIPS
$6.84B
$215K 0.05%
+12,176
New +$234K
ONT
441
Onterris Inc
ONT
$710M
$215K 0.05%
+8,666
New +$229K
JOYY
442
JOYY Inc
JOYY
$3.73B
$214K 0.05%
+3,309
New +$202K
ADPT icon
443
Adaptive Biotechnologies
ADPT
$3.56B
$214K 0.05%
13,150
-4,799
-27% -$78.3K
ONON icon
444
On Holding
ONON
$11.9B
$213K 0.05%
+4,590
New +$198K
SRPT icon
445
Sarepta Therapeutics
SRPT
$1.66B
$212K 0.05%
+9,866
New +$208K
AG icon
446
First Majestic Silver
AG
$8.05B
$212K 0.05%
+12,731
New +$177K
NYT icon
447
New York Times
NYT
$11.6B
$211K 0.05%
3,039
-6,997
-70% -$434K
EQT icon
448
EQT Corp
EQT
$33.2B
$210K 0.05%
+3,910
New +$220K
FSK icon
449
FS KKR Capital
FSK
$2.98B
$208K 0.05%
14,028
-1,136
-7% -$17.2K
ING icon
450
ING
ING
$93.8B
$207K 0.05%
7,407
-9,130
-55% -$235K

Similar funds

Bridgefront Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Bridgefront Capital held 829 positions worth $398M, up 17% from $340M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Bridgefront Capital deployed $62.7M of net new capital in Q4 2025, opening 268 new positions and adding to 140 existing holdings. Its largest new stake was e.l.f. Beauty: 59,427 shares worth $4.52M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Lam Research, an estimated $4.81M trimmed.

  • Bridgefront Capital's largest Q4 2025 buy was e.l.f. Beauty: 59,427 shares worth $4.52M.
  • Bridgefront Capital added most to Microsoft in Q4 2025, an estimated $3.81M increase.
  • Bridgefront Capital's biggest Q4 2025 reduction was Lam Research, cutting an estimated $4.81M.
  • Bridgefront Capital fully exited Honeywell in Q4 2025, selling an estimated $3.09M.
  • Bridgefront Capital's ten largest holdings make up 9.7% of its $398M portfolio in Q4 2025.
  • Bridgefront Capital opened 268 new positions and closed 337 in Q4 2025.
  • Bridgefront Capital's portfolio value rose 17% quarter-over-quarter to $398M.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.